Rabavert rabies vacc w-diluents
Ended Awarded Last action
- Contract number
- SPE2DR26F98XT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,965
Award facts
- Contract value 100% obligated
- $30,964.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $30,964.57 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 23, 2026, for the supply of Rabavert rabies vaccine with diluents. The contract, which carries no set-aside designation, was competitively awarded and is scheduled for completion by January 26, 2026. Performance will be fulfilled from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vendor agreement running through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), a major pharmaceutical distributor and healthcare solutions provider that holds significant federal contract relationships with both the DLA and Department of Veterans Affairs. The parent company, Cencora, maintains an even larger IDC with DLA valued at up to $999.9 billion through December 31, 2031, underscoring the strategic importance of pharmaceutical supply to federal military and veteran healthcare systems. AmerisourceBergen's extensive portfolio demonstrates capability in supplying a comprehensive range of medical commodities, including vaccines, specialty medications, and generic drugs across multiple therapeutic domains supporting defense health operations globally.
Quick answers
Who was awarded contract SPE2DR26F98XT?
SPE2DR26F98XT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26F98XT worth?
The government has obligated $30,965 on SPE2DR26F98XT.
Is contract SPE2DR26F98XT an order under another contract?
Yes. SPE2DR26F98XT is a delivery order under SPE2DR25D7060, an indefinite delivery contract.
Was contract SPE2DR26F98XT competed?
The extent of competition for SPE2DR26F98XT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award